Back
Pliant Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
17
PLRX
Pliant Therapeutics
Last Price:
$1.37
Seasonality Move:
33.04%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight selling pressure.
Pliant Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.44 | Sell |
| 20-day SMA: | 1.49 | Sell |
| 50-day SMA: | 1.48 | Sell |
| 200-day SMA: | 9.37 | Sell |
| 8-day EMA: | 1.44 | Sell |
| 20-day EMA: | 1.49 | Sell |
| 50-day EMA: | 2.38 | Sell |
| 200-day EMA: | 7.82 | Sell |
Pliant Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 38.44 | Sell |
| Chaikin Money Flow: | -136326 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.36 - 1.56) | Sell |
| Bollinger Bands (100): | (0.46 - 10.6) | Sell |
Pliant Therapeutics Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
-
Pliant Therapeutics share price is 1.36 while PLRX 8-day simple moving average is 1.44, which is a Sell signal.
-
The stock price of PLRX is 1.36 while Pliant Therapeutics 20-day SMA is 1.49, which makes it a Sell.
-
Pliant Therapeutics 50-day simple moving average is 1.48 while PLRX share price is 1.36, making it a Sell technically.
-
PLRX stock price is 1.36 and Pliant Therapeutics 200-day simple moving average is 9.37, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
17
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a SellThe current Pliant Therapeutics [PLRX] share price is $1.36. The Score for PLRX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
83.5M
Price in USD:
1.36
Share Volume:
590.7K
Pliant Therapeutics 52-Week Range
52-Week High:
16.52
52-Week Low:
1.10
Sell
17
Pliant Therapeutics (PLRX)
is a Sell
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?The Pliant Therapeutics stock price is 1.36 USD today.
-
Will PLRX stock go up or go down?Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Pliant Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is overvalued.
Is Pliant Therapeutics Stock a Buy?
-
Pliant Therapeutics share price is 1.36 while PLRX 8-day exponential moving average is 1.44, which is a Sell signal.
-
The stock price of PLRX is 1.36 while Pliant Therapeutics 20-day EMA is 1.49, which makes it a Sell.
-
Pliant Therapeutics 50-day exponential moving average is 2.38 while PLRX share price is 1.36, making it a Sell technically.
-
PLRX stock price is 1.36 and Pliant Therapeutics 200-day simple moving average is 7.82, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.12 per share, an increase this year of $1.09 per share, and an increase next year of $0.06 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
-
PLRX Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Pliant Therapeutics is a Sell
-
Pliant Therapeutics Relative Strength Index (RSI) is 38.44, which suggest Pliant Therapeutics is oversold
-
The Bollinger Bands (25) for Pliant Therapeutics is (1.36 - 1.56), which suggest Pliant Therapeutics is a Sell
-
The Bollinger Bands (100) for Pliant Therapeutics is (0.46 - 10.6), which suggest Pliant Therapeutics is a Sell
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.